[

university of oxford

]

Covid leading to loss of grey matter, hits cognition: Study

  • The scans showed loss of grey matter, indicative of damage, and the areas affected involved functions relating to smell and taste, cognition and memory formation. Most of the patients examined had mild-to-moderate disease.
In all, 782 people who previously underwent brain scans participated, and of these, 394 subsequently tested positive for Sars-Cov-2. (HT file photo)
In all, 782 people who previously underwent brain scans participated, and of these, 394 subsequently tested positive for Sars-Cov-2. (HT file photo)
Updated on Jun 19, 2021 12:08 AM IST
Copy Link
By HT Correspondent, New Delhi

Covishield shelf life extended from 6 to 9 months: Govt

Concerns regarding Covid-19 vaccine wastage were raised as SII began production of the Covid-19 vaccine before being granted emergency use authorisation for use in India on January 3.
Covishield, which has been developed by Oxford-AstraZeneca against Covid-19, is locally manufactured and sold by the Serum Institute of India (SII).(Bloomberg)
Covishield, which has been developed by Oxford-AstraZeneca against Covid-19, is locally manufactured and sold by the Serum Institute of India (SII).(Bloomberg)
Updated on Mar 31, 2021 06:19 AM IST
Copy Link
By Rhythma Kaul, New Delhi

Oxford study says existing Covid vaccines may protect against Brazilian variant

Data from a University of Oxford study suggests that existing Covid-19 vaccines may protect against the Brazilian variant of coronavirus
Oxford study says existing Covid vaccines may protect against Brazilian variant(Photo by Hakan Nural on Unsplash)
Oxford study says existing Covid vaccines may protect against Brazilian variant(Photo by Hakan Nural on Unsplash)
Updated on Mar 18, 2021 04:57 PM IST
Copy Link
Reuters |

Covid-19: Oxford study hint AstraZeneca vaccine effective against Brazil variant

The data from a study conducted at the University of Oxford indicates that the Covid-19 vaccine developed by AstraZeneca PLC will not need to be modified in order to protect against the Brazilian variant, which is believed to have originated in the Amazonian city of Manaus
Covid-19: Oxford study hint AstraZeneca vaccine effective against Brazil variant(Photo by Ivan Diaz on Unsplash)
Covid-19: Oxford study hint AstraZeneca vaccine effective against Brazil variant(Photo by Ivan Diaz on Unsplash)
Updated on Mar 05, 2021 08:30 PM IST
Copy Link
Reuters |

Oxford Covid-19 shot less effective against South African variant: Study

Among coronavirus variants currently most concerning for scientists and public health experts are the so-called British, South African and Brazilian variants, which appear to spread more swiftly than others.
AstraZeneca vaccine is ready to be used at the Wellcome Centre in Ilford, east London, Friday.(AP Photo )
AstraZeneca vaccine is ready to be used at the Wellcome Centre in Ilford, east London, Friday.(AP Photo )
Published on Feb 07, 2021 06:24 AM IST
Copy Link
Reuters |

Oxford says Covid-19 vaccine with AstraZeneca works against UK variant

The variant, first identified in Kent, southern England, is more easily transmissible, prompting many countries to restrict travel to Britain. It also led to a spike in infections that forced a new national lockdown in England last month.
AstraZeneca vaccine is ready to be used at the Wellcome Centre in Ilford, east London, Friday, Feb. 5, 2021.(AP)
AstraZeneca vaccine is ready to be used at the Wellcome Centre in Ilford, east London, Friday, Feb. 5, 2021.(AP)
Published on Feb 06, 2021 04:40 AM IST
Copy Link
Reuters | , London

Oxford vaccine reduces transmission: UK study

With almost 76% efficacy in preventing symptomatic illness, vaccine can also reduce the risk of transmission by around 67%: Study.
“It slows transmission by around two-thirds, so it categorically supports the strategy that we’re undertaking,” UK’s health secretary Matt Hancock said.(AP)
“It slows transmission by around two-thirds, so it categorically supports the strategy that we’re undertaking,” UK’s health secretary Matt Hancock said.(AP)
Updated on Feb 04, 2021 07:08 AM IST
Copy Link
Agencies | By HT Correspondent, New Delhi/london

Oxford finds AstraZeneca's Covid-19 shot 76% effective for 3 months

The findings of the pre-print paper, which had not been peer-reviewed, supported Britain's decision to extend the interval between initial and booster doses of the shot to 12 weeks, Oxford said on Tuesday.
The results for the AstraZeneca/Oxford vaccine, gathered from trials in Britain, Brazil and South Africa, showed that immune responses were boosted with a longer interval to the second dose among participants aged 18 to 55 years.(AFP)
The results for the AstraZeneca/Oxford vaccine, gathered from trials in Britain, Brazil and South Africa, showed that immune responses were boosted with a longer interval to the second dose among participants aged 18 to 55 years.(AFP)
Updated on Feb 03, 2021 01:12 AM IST
Copy Link
Reuters | , London

Covishield: A timeline of the Covid-19 vaccine manufactured by SII

Pune-based Serum Institute of India partnered with the Oxford University to manufacture their Covishield vaccine in India.
On January 16, 2021, the first dose of the Covishield vaccine was administered to recipients based on a priority list prepared by the government.(Bloomberg)
On January 16, 2021, the first dose of the Covishield vaccine was administered to recipients based on a priority list prepared by the government.(Bloomberg)
Updated on Jan 16, 2021 11:21 PM IST
Copy Link
By hindustantimes.com | Written by Srivatsan K C

UK rolls out AstraZeneca Covid-19 vaccine; 82-year-old gets first shot

“I am so pleased to be getting the COVID vaccine today and really proud that it is one that was invented in Oxford,” 82-year-old Brian Pinker said after receiving the vaccine.
The UK government had already procured 100 million doses of the AstraZeneca Covid-19 vaccine and more than half a million doses were ready for administering on Monday.(Bloomberg)
The UK government had already procured 100 million doses of the AstraZeneca Covid-19 vaccine and more than half a million doses were ready for administering on Monday.(Bloomberg)
Updated on Jan 04, 2021 05:07 PM IST
Copy Link
Hindustan Times, New Delhi | By hindustantimes.com | Edited by Srivatsan K C

UK approves AstraZeneca-Oxford University Covid-19 vaccine: All you need to know

Health minister Matt Hancock hailed the approval as a moment of cheer for the UK and the world. He also announced that 100 million doses of the vaccine has been pre-ordered by the British government and the National Health Service (NHS) will begin the deployment of the vaccine from Monday (January 4, 2021).
Prime Minister Boris Johnson welcomed the approval of the AstraZeneca-University of Oxford Covid-19 vaccine, calling it a “truly fantastic news.”(AFP)
Prime Minister Boris Johnson welcomed the approval of the AstraZeneca-University of Oxford Covid-19 vaccine, calling it a “truly fantastic news.”(AFP)
Updated on Dec 30, 2020 05:21 PM IST
Copy Link
Hindustan Times, New Delhi | By hindustantimes.com | Edited by Srivatsan K C

Zomato ranked worst on ‘Fairwork’ ratings, co-founder pledges to improve work conditions | Ranking

The study focussed on fair pay, fair conditions, fair contracts, fair management, and fair representation, awarding one point for meeting the basic standard and an additional point for achieving a higher standard.
The Fairwork India team had conducted a study on how platform work is perceived and experienced by workers on these platforms.(Photo by Indranil Bhoumik/mint)
The Fairwork India team had conducted a study on how platform work is perceived and experienced by workers on these platforms.(Photo by Indranil Bhoumik/mint)
Updated on Dec 16, 2020 08:53 PM IST
Copy Link
Hindustan Times, New Delhi | By hindustantimes.com | Edited by Kunal Gaurav

UK’s AstraZeneca says buying US biotech firm Alexion for $39 billion

“Alexion has established itself as a leader in complement biology, bringing life-changing benefits to patients with rare diseases,” AstraZeneca chief executive Pascal Soriot said in a statement, announcing the year’s biggest deal in the pharma sector.
Both boards have agreed to the cash-and-stock deal, which values Alexion at $175 a share, a premium of 45 percent to the Boston-based company’s closing price on Friday.(REUTERS)
Both boards have agreed to the cash-and-stock deal, which values Alexion at $175 a share, a premium of 45 percent to the Boston-based company’s closing price on Friday.(REUTERS)
Updated on Dec 13, 2020 06:04 AM IST
Copy Link
London | By Agence France-Presse | Posted by Prashasti Singh

AstraZeneca vaccine better at stopping Covid-19 than slowing transmission: Report

A vaccine from the University of Oxford and AstraZeneca Plc shows only a limited ability to stop transmission of the coronavirus despite preventing Covid-19 illness in a majority of those who are infected.
As promising vaccine data keeps rolling in, one of the central unanswered questions has been whether inoculations can not only stop people from getting sick but also slow the spread of the virus, a key element for reopening economies.(Reuters file photo)
As promising vaccine data keeps rolling in, one of the central unanswered questions has been whether inoculations can not only stop people from getting sick but also slow the spread of the virus, a key element for reopening economies.(Reuters file photo)
Updated on Dec 09, 2020 03:39 PM IST
Copy Link
By Bloomberg | Posted by Niyati Singh

PM Modi to visit Serum Institute of India in Pune on November 28

The Prime Minister, according to officials, will visit various facilities at SII’s Hadapsar campus where the Pune firm has began the production of Covishield vaccine
Prime Minister Narendra Modi.(PTI)
Prime Minister Narendra Modi.(PTI)
Updated on Nov 26, 2020 01:59 PM IST
Copy Link
Hindustan Times, Pune | By Yogesh Joshi

The woman behind the Oxford-AstraZeneca Covid-19 vaccine

Professor Sarah Gilbert was born in Kettering, Northamptonshire in April 1962, both her parents were not in STEM fields. She started working on vaccine research in 1994 with Adrian Hill, who is now the director of the Jenner Institute
This Irish-born virologist started her journey in 1994 with malaria vaccine research and has since then worked on shots against Ebola and Middle East Respiratory Syndrome(Twitter)
This Irish-born virologist started her journey in 1994 with malaria vaccine research and has since then worked on shots against Ebola and Middle East Respiratory Syndrome(Twitter)
Updated on Nov 24, 2020 08:19 AM IST
Copy Link
Hindustan Times, New Delhi | By hindustantimes.com | Edited by Ayshee Bhaduri

As vaccine trials end, where do Covid-19 treatments stand?

Most Covid-19 treatments fall under three broad categories, antivirals that prevent the virus from multiplying, immune-modulators that regulate the immune response, and combinations that use multiple mechanisms of action.
Most Covid-19 treatments fall under three broad categories, antivirals that prevent the virus from multiplying, immune-modulators that regulate the immune response, and combinations that use multiple mechanisms of action.(AP)
Most Covid-19 treatments fall under three broad categories, antivirals that prevent the virus from multiplying, immune-modulators that regulate the immune response, and combinations that use multiple mechanisms of action.(AP)
Updated on Nov 24, 2020 05:35 AM IST
Copy Link
Hindustan Times, New Delhi | By Sanchita Sharma

Covid-19: Boost for India as Oxford vaccine candidate shot up to 90% successful

The makers of the vaccine will now approach regulators with the full data from the trial to seek an emergency use licence, which will allow for it to be given to people who need it at the earliest: health care workers at the frontlines of the pandemic and people vulnerable to serious illness.
Known as AZD1222, the vaccine has long been the best hope for India — it is cheaper to make, easier to store and distribute, faster to scale up than its two rivals that have shown promise till now.(Reuters)
Known as AZD1222, the vaccine has long been the best hope for India — it is cheaper to make, easier to store and distribute, faster to scale up than its two rivals that have shown promise till now.(Reuters)
Updated on Nov 24, 2020 01:20 AM IST
Copy Link
Hindustan Times, New Delhi | By Prasun Sonwalkar and Rhythma Kaul, New Delhi

For the first time, can see route out of Covid-19 pandemic: UK PM Boris Johnson

Outlining post-lockdown measures to come into effect from December 3, PM Johnson told the House of Commons virtually that developments in vaccines mean the “scientific cavalry is now in sight”
Britain's Prime Minister Boris Johnson speaks during the weekly question-time debate at the House of Commons in London, Britain, on November 11, 2020.(REUTERS/ FILE)
Britain's Prime Minister Boris Johnson speaks during the weekly question-time debate at the House of Commons in London, Britain, on November 11, 2020.(REUTERS/ FILE)
Updated on Nov 23, 2020 11:57 PM IST
Copy Link
Hindustan Times, London | By Prasun Sonwalkar

‘Highly effective’ Oxford vaccine raises hopes of normal life from April

The analysis of its data from the trial in the UK and Brazil said the AZD1222 vaccine is highly effective in preventing Covid-19, with no hospitalisations or severe cases reported in participants receiving the vaccine.
In this file photo taken on September 11, a laboratory technician supervises capped vials during filling and packaging tests for the large-scale production and supply of the University of Oxford’s Covid-19 vaccine candidate, AZD1222.(AFP file)
In this file photo taken on September 11, a laboratory technician supervises capped vials during filling and packaging tests for the large-scale production and supply of the University of Oxford’s Covid-19 vaccine candidate, AZD1222.(AFP file)
Updated on Nov 23, 2020 06:55 PM IST
Copy Link
Hindustan Times, London | By Prasun Sonwalkar , edited by Vinod Janardhanan

News updates from Hindustan Times: ‘Is lockdown only solution?’: Delhi HC refuses to entertain plea seeking lockdown with immediate effect all the latest news

Here are today’s top news, analysis and opinion. Know all about the latest news and other news updates from Hindustan Times.
A massive crowd of people shopping while violating social distancing norms after the Covid-19 outbreak, in Sarojini Nagar market in New Delhi on Sunday.(ANI Photo)
A massive crowd of people shopping while violating social distancing norms after the Covid-19 outbreak, in Sarojini Nagar market in New Delhi on Sunday.(ANI Photo)
Updated on Nov 23, 2020 01:13 PM IST
Copy Link
Hindustan Times, New Delhi | By hindustantimes.com

Astra-Oxford vaccine prevents average of 70% of Covid-19 cases

The findings were reviewed after 131 trial participants contracted Covid-19, and are based on two different dosing regimes.
The vaccine stopped an average of 70% of participants in a study from falling ill, an early analysis of the data show.(AFP image)
The vaccine stopped an average of 70% of participants in a study from falling ill, an early analysis of the data show.(AFP image)
Updated on Nov 23, 2020 02:10 PM IST
Copy Link
By Bloomberg | Posted by Prashasti Singh

As some countries rush to buy Covid-19 vaccine in advance, will others be left out?

Many have pinned their hopes on vaccines as reports of two of them, including the candidates of Pfizer and BioNTech and Moderna, being highly effective and others clearing advanced stages of trials come in.
Pfizer and BioNTech’s vaccine candidate BNT162b2 was recently found 95% effective without any major safety concerns and Moderna announced that preliminary phase three trial data showed its vaccine was 94.5% effective.(Reuters)
Pfizer and BioNTech’s vaccine candidate BNT162b2 was recently found 95% effective without any major safety concerns and Moderna announced that preliminary phase three trial data showed its vaccine was 94.5% effective.(Reuters)
Updated on Nov 21, 2020 10:29 AM IST
Copy Link
Hindustan Times, New Delhi | By hindustantimes.com | Edited by Prashasti Singh

Oxford scientists expect Covid-19 vaccine data by Christmas

Oxford is developing its vaccine in conjunction with the drugmaker AstraZeneca.
A test tube labelled with the vaccine is seen in front of AstraZeneca logo in this illustration.(Reuters File Photo)
A test tube labelled with the vaccine is seen in front of AstraZeneca logo in this illustration.(Reuters File Photo)
Published on Nov 20, 2020 06:54 AM IST
Copy Link
London | By Associated Press | Posted by Kanishka Sarkar

Oxford University Covid-19 vaccine ‘encouraging’ for older age groups

The findings published in ‘Lancet’ are based on 560 healthy adult volunteers and show that the ChAdOx1 nCoV-19 vaccine is “safe and well tolerated” with a lower reactogenicity profile in older adults than in younger adults, meaning the older age groups could build immunity to the disease.
A scientist works at the manufacturing laboratory where a vaccine against the coronavirus disease (Covid-19) has been produced at the Oxford Vaccine Group's facility at the Churchill Hospital in Oxford, Britain.(Reuters/ File photo)
A scientist works at the manufacturing laboratory where a vaccine against the coronavirus disease (Covid-19) has been produced at the Oxford Vaccine Group's facility at the Churchill Hospital in Oxford, Britain.(Reuters/ File photo)
Updated on Nov 19, 2020 02:09 PM IST
Copy Link
Press Trust of India | By Press Trust of India | Posted by Mallika Soni

Playing video games is good for well-being, shows Oxford research

Lockdowns and stay-at-home spells have led to more people playing video games and connecting with others through social media. Researchers used industry data on actual play time for popular video games to arrive at these conclusions
Nintendo Switch game consoles are on display at Nintendo's official store in the Shibuya district of Tokyo.(AP/ FILE)
Nintendo Switch game consoles are on display at Nintendo's official store in the Shibuya district of Tokyo.(AP/ FILE)
Published on Nov 16, 2020 07:33 PM IST
Copy Link
Hindustan Times, London | By Prasun Sonwalkar

Europe’s new drug agency head warns of vaccine safety challenges

Monitoring the safety of Covid-19 vaccines, especially those relying on novel technologies such as messenger RNA, will be one of the biggest challenges once shots are rolled out widely.
Positive results won’t “remove the need to monitor very carefully these new vaccines, particularly the first couple that seem to be coming through,” Emer Cooke.(Unsplash)
Positive results won’t “remove the need to monitor very carefully these new vaccines, particularly the first couple that seem to be coming through,” Emer Cooke.(Unsplash)
Updated on Nov 16, 2020 06:03 PM IST
Copy Link
By Bloomberg | Posted by Jahnavi Gupta

Oxford Covid-19 vaccine results due next month, raising hopes of 2021 rollout

The Oxford/AstraZeneca vaccine is expected to be one of the first from big pharma to be submitted for regulatory approval, along with Pfizer and BioNTech’s candidate.
A test tube labelled with the Vaccine is seen in front of AstraZeneca logo(Reuters Photo)
A test tube labelled with the Vaccine is seen in front of AstraZeneca logo(Reuters Photo)
Published on Nov 05, 2020 01:02 AM IST
Copy Link
London | By Reuters | Posted by Kanishka Sarkar

Covid-19 vaccine likely to be available by Jan, will be affordable: Adar Poonawalla

The SII is working in collaboration with British-Swedish pharma major AstraZeneca to produce the potential Covid-19 vaccine Covishield.
Poonawalla said that the vaccine shot has so far been given to thousands of people in India and abroad.(Photo courtesy: Serum Institute of India)
Poonawalla said that the vaccine shot has so far been given to thousands of people in India and abroad.(Photo courtesy: Serum Institute of India)
Updated on Nov 05, 2020 01:08 PM IST
Copy Link
Hindustan Times, New Delhi | By hindustantimes.com | Edited by Kanishka Sarkar

Delhi based student lands research internship offer from over 10 world famous universities

At times, these dreams get dashed at the selection level of some top-notch universities as students are not passed-out from renowned institutions.
Delhi-based Abhishek Agrahari, an engineering student,received internship offers from the UK’s University of Oxford and the USA’s Pennsylvania State University and the University of Illinois, among others.(ANI)
Delhi-based Abhishek Agrahari, an engineering student,received internship offers from the UK’s University of Oxford and the USA’s Pennsylvania State University and the University of Illinois, among others.(ANI)
Updated on Oct 27, 2020 05:15 PM IST
Copy Link
New Delhi | By Asian News International| Posted by Akhilesh Nagari
SHARE
  • 1
  • 2
  • 3
  • ...
Story Saved
×
Saved Articles
My Reads
Sign out
New Delhi 0C
Thursday, October 21, 2021